[Intestinal flora and Crohn's disease].

Area of Science:

• Gastroenterology and Immunology
• Microbiome-Host Interactions
• Genetic Susceptibility in Inflammatory Bowel Disease (IBD)

Context:

• Inflammatory bowel diseases (IBD) pathogenesis involves stages of initiation, amplification, and healing, with luminal bacteria implicated.
• Macrophage and T-cell activation, driven by a breakdown in tolerance to enteric flora, is an early event in IBD.
• Factors contributing to this loss of tolerance include dysbiosis, decreased barrier function, and impaired mucosal clearance.

Purpose:

• To explore the role of gut bacteria and host genetic factors in the pathogenesis of inflammatory bowel diseases (IBD).
• To investigate the link between immune responses to enteric bacteria and mucosal inflammation in IBD.
• To understand the functional implications of NOD2/CARD15 variants in Crohn's disease pathogenesis.

Summary:

• Gut bacteria and their products are incriminated in the initiation and perpetuation of chronic intestinal inflammation in IBD.
• Adherent-invasive Escherichia coli and specific bacterial virulence factors are potential contributors to inflammation in Crohn's disease.
• NOD2/CARD15 gene variants, particularly those affecting the leucine-rich-repeat (LRR) domain's recognition of bacterial peptidoglycans, are linked to Crohn's disease susceptibility.

Impact:

• Identifies potential bacterial targets and host genetic factors involved in IBD pathogenesis.
• Highlights the critical role of the innate immune system's recognition of microbial components in IBD.
• Provides a foundation for further research into the pathophysiological mechanisms of NOD2/CARD15 variants in the intestinal mucosa.